Background and objective: Asthma in adults is associated with a persistent reduction in lung function from childhood, but this link has not been assessed back to infancy. Reduced infant lung function (ILF), a measure of antenatal and infant lung growth, is associated with asthma into adolescence. Our aim was to assess whether this link persists into adulthood and whether ILF can predict the remission of asthma symptoms in young adults. Methods: The study cohort was an unselected full-term birth cohort of 253 subjects enrolled antenatally with lung function assessments at 1, 6 and 12 months (maximum expiratory flow at functional residual capacity, V 0 maxFRC), and 6, 11, 18 and 24 years (spirometry) of age. Results: Infants with V 0 maxFRC in the lowest quartile at 1 month had an OR of 5.1 (95% CI: 2-13, P = 0.001) for asthma at 24 years. Subjects with asthma at 24 years had a mean V 0 maxFRC at 1 month of 69% predicted (95% CI: 48-90%) versus 110% (95% CI: 101-119%) in non-asthmatic patients (P = 0.001). Subjects with current versus resolved asthma symptoms at 24 years had a mean V 0 maxFRC at 1 month of 69% predicted (95% CI: 53-84%) versus 105% (88-123%), respectively (P = 0.003). Subjects with current asthma at 24 years had persistently lower lung function from infancy with a mean reduction of 16.2% (95% CI: 8.1-24.3%, P < 0.0001). Conclusion: Reduced lung function in early infancy is predictive of persistent asthma in young adults and a persistent reduction in lung function, suggesting abnormal lung development and growth in utero or very early in life.
INTRODUCTION
Asthma in childhood has been linked to antenatal and early life factors prior to the development of symptoms including genotype, respiratory infections and early allergic sensitization. [1] [2] [3] Asthma in adults is associated with bronchial hyperresponsiveness, reduced lung function as measured by spirometry and allergies in school-aged children, 4, 5 but this link has not been extended back to the first few years of life, during crucial lung development.
Lung function tests measure lung growth and development. For infants, rapid thoraco-abdominal compression (RTC) measures maximum expiratory flow at functional residual capacity (V 0 maxFRC) during a chest squeeze using an inflatable jacket. 6 More recent techniques, such as the 'raised volume RTC' technique, first inflate the infants' lungs. 7 Longitudinal studies have shown that lung function measured by spirometry tracks from infancy through into adulthood. 8, 9 Reduced lung function in neonates is associated with current asthma during childhood and a history of asthma in adolescence, but this has not been assessed into adulthood. 8, 10, 11 However, reduced infant lung function (ILF) is associated with wheeze throughout childhood and adolescence but not into adulthood. 9, [12] [13] [14] [15] Yet, wheeze can encompass incidental airway irritation from 
SUMMARY AT A GLANCE
Asthma associates with a persistent reduction in lung function from childhood into adulthood and infant lung function is predictive of childhood asthma. We have shown that reduced lung function in infancy is also predictive of asthma in young adults and can help differentiate those whose symptoms will resolve before adulthood. tobacco smoke or a viral infection, while an asthma diagnosis suggests chronic lower airway inflammation leading to airway hyperresponsiveness and recurrent symptoms.
Asthma is associated with a consistent reduction in lung function from mid-childhood into adulthood, with minimal further deficit after adolescence. 5, 8, 9, 16, 17 We predict that this deficit can be traced back to infancy. Our concern is that this deficit may progress to COPD without requiring any further insults. [18] [19] [20] Approximately 30% of subjects with childhood asthma have symptom resolution by early adulthood, with preschool factors such as atopy, airway responsiveness and female gender associated with the persistence of symptoms. 4, 5 However, a comparison between subjects with resolved versus persistent disease has not been made using early functional testing. Therefore, the influence of ILF, as a marker of in utero lung development, on the persistence of asthma into adulthood is not known.
The aim of this study was to use comprehensive longitudinal data from a well-established birth cohort to test the hypotheses that reduced lung function in infancy is: (1) associated with asthma in early adulthood and (2) can predict symptom persistence versus remission.
METHODS
The Perth Infant Asthma Follow-up (PIAF) cohort is a longitudinal birth cohort of 253 participants, recruited from an Australian maternity hospital between 1987 and 1990. The initial study design and methods have previously been described. 21 There were no selection criteria based on family history of asthma or atopy. The majority of infants (95%) were of Caucasian ethnicity. Exclusion criteria included preterm birth or respiratory symptoms before the first assessment at 1 month of age. Subjects were reassessed at 6 and 12 months, and 6, 11, 18 and 24 years of age. Each follow-up was approved by the Princess Margaret Hospital Human Ethics Committee (2054EP) and parental or participant consent was obtained for each assessment. Contact details of subjects, both parents and two close relatives were updated at each assessment. For the 18-and 24-year assessments, data linkage using the electoral role of Western Australia identified new addresses for several subjects. Due to compulsory voting in Australia, the electoral role contains a comprehensive list of those eligible to vote within the state. A private Facebook page was set-up for the 24-year assessments to contact and communicate with participants.
A questionnaire was completed at each assessment. All asthma definitions were based on a physician diagnosis. 'Current asthma' was defined by symptoms or use of asthma medications in the previous 12 months and 'resolved asthma' was defined by no symptoms or asthma medication use in the previous 12 months. 'asthma-ever' included subjects with current and resolved symptoms. 'Recent wheeze' was defined as at least one episode of self-reported wheeze in the previous 12 months. RTC during tidal breathing was used according to ATS guidelines for ILF assessments at 1, 6 and 12 months of age 6 and the average of five acceptable V 0 maxFRC values was recorded. Percent predicted values were calculated following adjustment for maternal smoking during pregnancy, gender, length and weight. 22 From 6 to 24 years, a portable spirometer (Pneumocheck Spirometer 6100; Welch-Allyn, Skaneateles Falls, NY, USA) was used according to ATS guidelines to record and calculate forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), FEV 1/ /FVC and FEF25-75%. 23, 24 Global lung Initiative reference ranges were used to calculate percent of predicted based on gender, age, height and ethnicity. 25 
Statistical analysis
Comparisons between subjects who were and were not assessed at 24 years were made using independent ttest and Pearson's chi-square test for continuous and categorical variables, respectively. V 0 maxFRC was adjusted for maternal smoking, height, weight and gender as per the validated formula described below and is reported as percent predicted. A general linear model was used to assess the difference in continuous lung function variables between categorical outcomes, both with and without adjustment for subject's current smoking status. Estimated marginal means are reported and differences analysed by independent t-test. The OR for current asthma based on V 0 maxFRC quartiles was calculated by logistic regression.
Internal z-scores of lung function variables were employed for longitudinal comparisons. A general estimating equation was applied to assess whether subjects with asthma at 24 years had persistently lower lung function throughout the study period (V 0 maxFRC at 1, 6, 12 months and FEF 25-75% from 6 to 24 years) using both z-scores and % predicted. This method adjusts for the inherent covariance in each subject, thus assessing the population average of the two groups for repeated measures. 26 The Wald statistic is reported. To assess lung function tracking, adjusted V 0 maxFRC at 1 month was divided into quartiles and one-way analysis of variance (ANOVA) assessed differences in zscores for FEV 1 , FEF25-75% and FEV 1 /FVC between all groups.
Two-sided P-value <0.05 determined statistical significance. Analyses were performed using SPSS Statistics for Windows, version 20.0. (2011, IBM Corp., Armonk, NY, USA).
RESULTS

Assessment at 24 years
Of the original 253 subjects, 241 had ILF testing at 1 month of age with a mean V 0 maxFRC of 100.5% predicted (SD = 48.5), of whom 2% had a V 0 maxFRC < −1.645 z-scores and 5% had >1.645 z-scores above the mean. Of the 150 subjects (59%) assessed at 24 years of age (mean = 24.2 years, SD = 1.4 years), 142 also performed ILF at 1 month of age. See Table 1 for characteristics of the original cohort and those seen at 24 years. Mean birth weight was 3.4 kg (SD = 0.48). There was significantly less maternal in utero smoking and more breastfeeding in the group seen at 24 years.
At 24 years of age, 16% (n = 24) had current asthma with symptoms in the previous 12 months and 28% (n = 42) had a history of asthma ever. Of those with asthma, 80% had symptoms before 6 years of age (n = 19). Recent wheeze was reported by 38% (n = 57) at 24 years.
ILF and asthma
Reduced lung function soon after birth was associated with asthma at 24 years of age. Mean V 0 maxFRC at 1 month for those with current asthma at 24 years was 68.7% predicted (95% CI: 47.7-89.7%) compared with 109.9% predicted (95% CI: 100.6-119%) for those without current asthma (P = 0.001) (Fig. 1) . This remained significant when adjusted for the smoking status of the subjects. There were no significant gender differences. A V 0 maxFRC of >100% predicted was attained by 53% of those who did not have asthma at 24 years, but only 13% of those with current asthma.
Conversely, reduced ILF was predictive of asthma at 24 years. Of those with a V 0 maxFRC in the lowest quartile (<66.3% predicted) at 1 month of age, 38% had current asthma at 24 years of age with an increased OR of 5.1 (95% CI: 2-13.2, P = 0.001), which remained significant when adjusted for subjects' current smoking status (OR = 4.8, P = 0.001).
Recent wheeze at 24 years was not associated with a difference in V 0 maxFRC at 1 month, when adjusted for the smoking status of the subjects (95% vs 107% predicted; 95% CI: 79-111% and 92-103%, respectively; P = 0.23).
Asthma remission at 24 years
Among those who were ever diagnosed with asthma, ILF at 1 month was higher in the group with resolved asthma compared with those with current symptoms at 24 years: mean V 0 maxFRC of 105% versus 69% predicted (95% CI: 88-123% and 53-84%, respectively; P = 0.003) (Fig. 1 ) and remained highly significant 
Infant lung function predicts adult asthma
when adjusted for the smoking status of the subjects (98% vs 65%, P = 0.009).
Asthma and longitudinal lung function
Longitudinally, subjects with current asthma at 24 years of age had persistently lower lung function throughout childhood, from infancy to 24 years with a mean reduction of 16.2% predicted, using V 0 maxFRC up to 12 months and FEF25-75% from 6 years (95% CI: 8.1-24.3%, Wald = 15.5, P < 0.0001), although the difference did not reach statistical significance at each cross-sectional time point (Fig. 2 ).
Asthma and current lung function
The presence or absence of current asthma at 24 years was associated with a significant difference in FEV 1 / FVC: mean 0.785 versus 0.827, respectively (P = 0.009). About 30% of females (n = 3) and 55% of males with asthma (n = 5) were in the abnormal range for FEV 1 / FVC compared with 7.5% of females and 12% of males who did not have asthma. 27 There was no difference between FEV 1 (92% vs 100%; 95% CI: 82-102% and 94-105%; P = 0.16), FEF25-75% (84% vs 96%; 95% CI: 73-96% and 89-102%; P = 0.061) or FVC (98% vs 101%; 95% CI: 89-108% and 99-106%; P = 0.59) in subjects with and without current asthma at 24 years. All analyses were adjusted for subjects' current smoking status.
DISCUSSION
As hypothesized, ILF at 1 month of age was a strong predictor of asthma in young adults; however, the difference of more than 40% was greater than expected. Previous studies have shown an association between ILF and asthma in childhood. 10, 11 However, the relationship in adults has not been clear. In the PIAF 18-year assessments, reduced ILF was associated with persistent wheeze and a history of asthma, but not persistent asthma at 18 years. However, the group with asthma were subdivided into three categories -remittent, lateronset and persistent -therefore may have been limited by the numbers in each subgroup. 8, 15 We did not find an association between ILF and current wheeze, consistent with the Tucson Study at 22 years. 9 Occasional episodes of wheeze can occur with a lower respiratory tract infection and do not necessarily indicate chronic lower airway inflammation and disease. Twice as many of our group reported current wheeze as current asthma at 24 years. The difference in their link to ILF suggests that subjects with more significant asthma symptoms had a defect in lung development or growth in utero or very early in life that persisted as a reduction in lung function into adulthood. ILF also differentiated subjects whose asthma symptoms would resolve by adulthood. Approximately 30% of subjects with asthma in childhood had a remission of their symptoms by 24 years, which is similar to other studies, although future relapse is still possible. 5, 28 Subjects with a resolution of their asthma by 24 years had similar V 0 maxFRC in infancy compared with those who never had asthma, in contrast to the group with ongoing symptoms, of whom only 13% had a V 0 maxFRC > 100% predicted at 1 month. V 0 maxFRC has a notoriously high variability particularly in neonates which may somewhat explain our outliers; however, we still found significant associations with asthma when using V 0 maxFRC quartiles. 29 These results suggest that ILF testing has potential as a marker for asthma persistence into adulthood.
Longitudinally, lung function (flow) was on average 16% predicted lower throughout childhood and into adulthood for subjects with asthma at 24 years. This is slightly higher than the 7% reduction seen in subjects with a prior history of asthma at the 18-year assessments, but the Dunedin Study showed lower lung function in subjects with persistent versus resolved wheeze by 26 years. 8, 16 Indeed, the reduction in lung function seen in adults with asthma may have its origin in the antenatal developing lung, as the deficit does not increase with time, and showed a slower rate of decline compared with non-asthmatic patients in the Melbourne Asthma Study. 5 We chose FEF25-75% as it correlates most closely with V 0 maxFRC. 15 The Global Lung Initiative values were used as these are most appropriate for longitudinal studies in this age group and zscores allowed for longitudinal comparisons. 30 We also found a small but statistically significant reduction in FEV 1 /FVC ratio in subjects with asthma at 24 years compared with non-asthmatic patients. Neither FEV 1 nor FVC on their own was significantly different, suggesting that the obstructive element is important in differentiating asthmatic patients, rather than the absolute size of the airways or lungs. Recent interest has focused on the early origins of COPD, examining factors other than smoking in its pathogenesis. 18 Childhood asthma has been proposed as a risk factor, possibly linked to the reduction in lung function as has been assessed in school-aged children. 5 However, the concept that COPD may have origins in antenatal lung development requires respiratory birth cohorts to be assessed for risk factors including respiratory function from birth and for follow-up over many decades.
This study has some minor limitations. First, 59% of the original cohort was seen at 24 years. Loss to followup is a common limitation of longitudinal studies over several decades with a risk of bias due to differential loss of subjects. However, in our comparative analysis, subjects seen at 24 years did not have significantly different ILF from those who were not seen. There was significantly less in utero smoke exposure and more breastfeeding, which is known to affect ILF, although the smoke exposure effect appears to ameliorate with age. 8 Our use of the RTC technique during tidal breathing for ILF testing was the gold standard in the 1980s when our cohort included infants. This has now been superseded by the use of raised-volume RTC technique, which better mimics the forced expiratory flow manoeuvres of spirometry. The tidal breathing method is less sensitive at detecting differences between groups due to less reproducibility in measurements. 7 However, this supports the validity of our findings, given we have identified associations using a slightly less sensitive method.
Very few longitudinal studies have included ILF in their assessments as it is time-consuming and the clinical implications are not known, and even fewer studies have continued following their cohort through into adulthood. Yet, we have demonstrated its importance as we have shown that abnormal lung function is present shortly after birth in subjects who have persistent asthma later on in life. These findings suggest that persistent asthma is related to an abnormal in utero or early lung growth pathology, which has implications for further understanding the pathogenesis and prognosis of the disease and that targeting this very early lung development may be necessary if we wish to manipulate respiratory outcomes in young adults.
